We came across a bullish thesis on Achieve Life Sciences, Inc. (ACHV) on Substack by Rogue Funds. In this article, we will summarize the bulls’ thesis on ACHV. Achieve Life Sciences, Inc. (ACHV)’s share was trading at $2.67 as of March 19th.
MeskPhotography/Shutterstock.com
Achieve Life Sciences presents a compelling investment opportunity with an exceptional risk-reward profile, particularly following its recent milestone update. The company’s lead drug, Cytisinicline, is a nicotine...
